Evenity 欧州連合 - フィンランド語 - EMA (European Medicines Agency)

evenity

ucb pharma s.a. - romosozumab - osteoporoosi - lääkkeet luusairauksien hoitoon - evenity on tarkoitettu vaikean osteoporoosin postmenopausaalisilla naisilla, joilla on suuri riski saada murtuma.

Fintepla 欧州連合 - フィンランド語 - EMA (European Medicines Agency)

fintepla

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - epilepsialääkkeet, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

Bimzelx 欧州連合 - フィンランド語 - EMA (European Medicines Agency)

bimzelx

ucb pharma s.a.   - bimekizumab - psoriasis - immunosuppressantit - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.

Atarax 2 mg/ml siirappi フィンランド - フィンランド語 - Fimea (Suomen lääkevirasto)

atarax 2 mg/ml siirappi

ucb pharma oy finland - hydroxyzine hydrochloride - siirappi - 2 mg/ml - hydroksitsiini

Atarax 25 mg tabletti, kalvopäällysteinen フィンランド - フィンランド語 - Fimea (Suomen lääkevirasto)

atarax 25 mg tabletti, kalvopäällysteinen

ucb pharma oy finland - hydroxyzine hydrochloride - tabletti, kalvopäällysteinen - 25 mg - hydroksitsiini

Zyrtec 1 mg/ml oraaliliuos フィンランド - フィンランド語 - Fimea (Suomen lääkevirasto)

zyrtec 1 mg/ml oraaliliuos

ucb pharma oy finland - cetirizine dihydrochloride - oraaliliuos - 1 mg/ml - setiritsiini

Obsidan Fe++ 100 mg kapseli, kova フィンランド - フィンランド語 - Fimea (Suomen lääkevirasto)

obsidan fe++ 100 mg kapseli, kova

ucb pharma gmbh - ferroglycin sulfate complex, ferrous sulfate heptahydrate, aminoacetic acid - kapseli, kova - 100 mg - ferroglysiinisulfaatti

Nootropil 1200 mg tabletti, kalvopäällysteinen フィンランド - フィンランド語 - Fimea (Suomen lääkevirasto)

nootropil 1200 mg tabletti, kalvopäällysteinen

ucb pharma oy finland - piracetam - tabletti, kalvopäällysteinen - 1200 mg - pirasetaami

Obsidan Fe++ Comp kapseli, kova フィンランド - フィンランド語 - Fimea (Suomen lääkevirasto)

obsidan fe++ comp kapseli, kova

ucb pharma gmbh - folic acid, ferroglycin sulfate complex - kapseli, kova - ferro-aminohappokompleksi

CIRRUS 5 mg / 120 mg säädellysti vapauttava tabletti フィンランド - フィンランド語 - Fimea (Suomen lääkevirasto)

cirrus 5 mg / 120 mg säädellysti vapauttava tabletti

ucb pharma oy finland - cetirizini dihydrochloridum,pseudoephedrini hydrochloridum - säädellysti vapauttava tabletti - 5 mg / 120 mg - pseudoefedriini, yhdistelmävalmisteet